Invited Speakers

	David Scadden (Harvard University and Massachusetts General Hospital, USA) SpeakerSpecial Lecture 1: Biology to therapy in the hematopoietic niche CommentatorSETP4: Hematopoiesis and Hematopoietic Environment
	Tomas Ganz (Depts. of Medicine and Pathology, UCLA, Los Angeles, USA) SpeakerSpecial Lecture 2: Systemic iron homeostasis: hormones, pathways, diseases
	Stephanie J. Lee (Fred Hutchinson Cancer Research Center (FHCRC) and University of Washington (UW), Seattle, WA,USA) SpeakerASH Special Lecture: Use of patient-reported outcomes in clinical care and research ChairJSH-ASH Joint Symposium(Symposium 9):Recent Advance in the Immunotherapy for Multiple Myeloma
	Elizabeth Macintyre (Hôpital Necker - Enfants Malades laboratoire onco-hématologie, France) SpeakerEHA Special Lecture: Immature T lymphoid malignancies: frontier states ChairJSH-EHA Joint Symposium(Symposium 8): New Phase of the Treatment of Intractable Lymphoma
	Merav Socolovsky (University of Massachusetts Medical School, USA) SpeakerPresidential Symposium:The Path from Stem Cells to Red Blood Cells The role of specialized cell cycles during erythroid lineage development
	Clara Camaschella (Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano, Italy) SpeakerPresidential Symposium:The Path from Stem Cells to Red Blood Cells The mutual crosstalk between iron and erythropoiesis
	Wen-Chien Chou (National Taiwan University Hospital, Taipei, Taiwan) ChairAsian Joint Panel Discussion:Virus-Associated Lymphoid Malignancies in Asian Countries
	Changiu Qu （National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China） SpeakerAsian Joint Panel Discussion: Virus-Associated Lymphoid Malignancies in Asian Countries ASCT or CAR-T in DLBCL
	Chieh-Lung Cheng (Attending Physician, Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan) SpeakerAsian Joint Panel Discussion:Virus-Associated Lymphoid Malignancies in Asian Countries Tumor immune microenvironment in hepatitis B virus-associated diffuse large B-cell lymphoma
	Udomsak Bunworasate (Division of Hematology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Thailand) SpeakerAsian Joint Panel Discussion:Virus-Associated Lymphoid Malignancies in Asian Countries Exploring therapeutic targets in extranodal NK/T-cell lymphoma
	Dok Hyun Yoon (Asan Medical Center, University of Ulsan College of Medicine, Korea) SpeakerAsian Joint Panel Discussion:Virus-Associated Lymphoid Malignancies in Asian Countries Significance of EBV-DNA in the plasma vs. whole blood for prognostication of ENKTL
	Pankaj Malhotra (Clinical Hematology and BMT unit, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India) SpeakerAsian Joint Panel Discussion:Virus-Associated Lymphoid Malignancies in Asian Countries Spectrum and real-world outcome of viruses associated lymphoproliferative disorders
	Ng Siok Bian (Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore) SpeakerAsian Joint Panel Discussion:Virus-Associated Lymphoid Malignancies in Asian Countries T/NK-cell lymphoproliferative diseases: Classification and recent advances
	Richard Stone (Chief-of-Staff, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School, USA) SpeakerSymposium 1:Molecular Pathogenesis and Targeting Agents in AML Advances in molecularly targeted therapy for AML
	Craig Jordan (University of Colorado, USA) SpeakerSymposium 1:Molecular Pathogenesis and Targeting Agents in AML Metabolic vulnerabilities of human AML stem cells
	Oussama Abla (The Hospital for Sick Children, Canada) SpeakerSymposium 2:Molecular Mechanism of Inflammation and Tumor in Histiocytic Disorders Non-Langerhans cell histiocytosis
	Sin Tiong Ong (Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore) SpeakerSymposium 3:Front Line of Genomic Analysis in Chronic Myeloid Leukemia Integrated multi-omics analysis of blast crisis chronic myeloid leukemia
	Simona Soverini (Hematology/Oncology "L. e A. Seràgnoli", University of Bologna, Italy) SpeakerSymposium 3:Front Line of Genomic Analysis in Chronic Myeloid Leukemia NGS-based BCR-ABL1 mutational analysis in CML patients with non-optimal response
	Susan Branford (Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia) SpeakerSymposium 3:Front Line of Genomic Analysis in Chronic Myeloid Leukemia Novel risk classification of chronic myeloid leukemia based on the genomic analysis at diagnosis
	Antonio M. Risitano (AORN San Giuseppe Moscati, Avellino, Italy) SpeakerSymposium 4:Recent Advances in the Field of Bone Marrow Failure Eltrombopag for the treatment of aplastic anemia: triple therapy as new first-line standard of care
	Satu Mustjoki (Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland) SpeakerSymposium 4:Recent Advances in the Field of Bone Marrow Failure Cellular and humoral immune responses in aplastic anemia
	Jan Joseph Melenhorst (University of Pennsylvania, USA) SpeakerSymposium 5:Post CD19CAR-T Immune Cell Therapy Response to second generation CAR T cell therapy: It takes(at least) two to tango CommentatorSETP2: Novel Immunotherapy for Hematological Malignancies
	Katy Rezvani (Chief, Section of Cellular Therapy, Medical Director of GMP and Cellular Therapy Laboratory, USA) SpeakerSymposium 5:Post CD19CAR-T Immune Cell Therapy Next generation engineered NK cells for the immunotherapy of cancer
	Robert Zeiser (Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany) SpeakerSymposium 6:A Better Understanding of GVHD Biology on the Basis of the Intestinal Immunity Advances in GVHD biology and therapy
	Jonathan Peled (Memorial Sloan Kettering Cancer Center, USA) SpeakerSymposium 6:A Better Understanding of GVHD Biology on the Basis of the Intestinal Immunity Microbiome and allo-HCT
	Andrés J. M. Ferreri (Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy) SpeakerJSH-EHA Joint Symposium(Symposium 8):New Phase of the Treatment of Intractable Lymphoma Primary CNS lymphoma: updates and breaking news
	Martin Dreyling (Department of Medicine III, University Hospital LMU München, Germany) SpeakerJSH-EHA Joint Symposium(Symposium 8):New Phase of the Treatment of Intractable Lymphoma Mantle cell lymphoma: time to change?
	Deepu Madduri (Hematology/ Oncology - Multilple Myeloma, Mount Sinai Hospital, USA) SpeakerJSH-ASH Joint Symposium(Symposium 9):Recent Advance in the Immunotherapy for Multiple Myeloma Anti-BCMA CAR-T therapy for multiple myeloma
	Suzanne Lentzsch (Columbia University, School of Medicine/Hematology-Oncology, New York, NY, USA) SpeakerJSH-ASH Joint Symposium(Symposium 9):Recent Advance in the Immunotherapy for Multiple Myeloma Current and future immunotherapy strategies in multiple myeloma CommentatorSETP3: Clinical and Basic Aspects of Multiple Myeloma
	Ralf H. Adams (Max Planck Institute for Molecular Biomedicine, Department Tissue Morphogenesis, and University of Muenster, Faculty of Medicine, Muenster, Germany) SpeakerSymposium 10:Recent Progress in Hematopoietic Regulation Heterogeneity and functional specialization of the bone microvasculature
	Andreas Trumpp (HI-STEM gGmbH, Heidelberg Institute for Stem Cell Technolgoy and Experimental Medicine, in the German Cancer Research Center(DKFZ),Germany) SpeakerSymposium 10:Recent Progress in Hematopoietic Regulation Normal and leukemic stem cells
	Amit Nathwani (Professor of Haematology Senior, National Institute for Health Research (NIHR)Investigator and Head of Department of Haematology University College London Royal Free Campus, UK) SpeakerSymposium 11:New Drug Modalities for the Treatment of Hemostatic and Thrombotic Disorders Gene therapy for the haemophilia
	Martin S. Tallman (Memorial Sloan Kettering Cancer Center, USA) CommentatorSETP1： Pathophysiology and Novel Treatment of Acute Leukemia